Orkla India IPO Review
Orkla India IPO has been reviewed by 1 analyst, and the overall consensus is Avoid — carrying a score of 40. Out of the 1 analysts who have covered this IPO, 0 recommend subscribing while 1 advises caution or avoidance — reflecting a cautious view from the analyst community.
The issue is priced in the band of ₹695-730 per share , with a minimum application size of 20 shares (minimum investment of approximately ₹14,600 at the upper band) . Subscription ran from 29 Oct 2025 to 31 Oct 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 1 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Orkla India IPO?
Based on analyst coverage tracked on this page, the overall verdict for Orkla India IPO is Avoid. Out of 1 analyst who have reviewed this IPO, 0 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 40 mean for Orkla India IPO?
The score of 40 is an aggregate of all analyst ratings tracked for Orkla India IPO. A score in this range reflects mixed views — some analysts are positive while others are cautious. Scroll down to read individual analyst verdicts for more context.
What are the listing gain expectations for Orkla India IPO?
Grey market data is not yet available for Orkla India IPO. As the subscription period approaches, GMP signals typically start forming. Check the GMP page for the latest updates.
What is the price band and lot size of Orkla India IPO?
Orkla India IPO was priced at ₹695-730 per share. The minimum lot size is 20 shares, making the minimum investment approximately ₹14,600 at the upper end of the price band. Subscription ran from 29 Oct 2025 to 31 Oct 2025.
Explore Orkla India IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!